<VariationArchive RecordType="classified" VariationID="996076" VariationName="NM_181523.3(PIK3R1):c.1735_1740del (p.Gln579_Tyr580del)" VariationType="Deletion" Accession="VCV000996076" Version="6" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2023-01-07" DateCreated="2021-02-07" MostRecentSubmission="2022-04-12">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="983782" VariationID="996076">
      <GeneList>
        <Gene Symbol="PIK3R1" FullName="phosphoinositide-3-kinase regulatory subunit 1" GeneID="5295" HGNC_ID="HGNC:8979" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>5q13.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="5" Accession="NC_000005.10" start="68215756" stop="68301821" display_start="68215756" display_stop="68301821" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="5" Accession="NC_000005.9" start="67511583" stop="67597648" display_start="67511583" display_stop="67597648" Strand="+" />
          </Location>
          <OMIM>171833</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_181523.3(PIK3R1):c.1735_1740del (p.Gln579_Tyr580del)</Name>
      <CanonicalSPDI>NC_000005.10:68295311:ACCAATAC:AC</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>5q13.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="5" Accession="NC_000005.10" start="68295312" stop="68295317" display_start="68295312" display_stop="68295317" variantLength="6" positionVCF="68295311" referenceAlleleVCF="GACCAAT" alternateAlleleVCF="G" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="5" Accession="NC_000005.9" start="67591140" stop="67591145" display_start="67591140" display_stop="67591145" variantLength="6" positionVCF="67591139" referenceAlleleVCF="GACCAAT" alternateAlleleVCF="G" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000005.10" sequenceAccession="NC_000005" sequenceVersion="10" change="g.68295314_68295319del" Assembly="GRCh38">
            <Expression>NC_000005.10:g.68295314_68295319del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000005.9" sequenceAccession="NC_000005" sequenceVersion="9" change="g.67591142_67591147del" Assembly="GRCh37">
            <Expression>NC_000005.9:g.67591142_67591147del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_012849.2" sequenceAccession="NG_012849" sequenceVersion="2" change="g.84559_84564del">
            <Expression>NG_012849.2:g.84559_84564del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001242466.2" sequenceAccession="NM_001242466" sequenceVersion="2" change="c.646_651del">
            <Expression>NM_001242466.2:c.646_651del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001229395.1" sequenceAccession="NP_001229395" sequenceVersion="1" change="p.Gln216_Tyr217del">
            <Expression>NP_001229395.1:p.Gln216_Tyr217del</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001822" Type="inframe_deletion" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_181504.4" sequenceAccession="NM_181504" sequenceVersion="4" change="c.925_930del">
            <Expression>NM_181504.4:c.925_930del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_852556.2" sequenceAccession="NP_852556" sequenceVersion="2" change="p.Gln309_Tyr310del">
            <Expression>NP_852556.2:p.Gln309_Tyr310del</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001822" Type="inframe_deletion" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_181523.3" sequenceAccession="NM_181523" sequenceVersion="3" change="c.1735_1740del" MANESelect="true">
            <Expression>NM_181523.3:c.1735_1740del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_852664.1" sequenceAccession="NP_852664" sequenceVersion="1" change="p.Gln579_Tyr580del">
            <Expression>NP_852664.1:p.Gln579_Tyr580del</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001822" Type="inframe_deletion" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_181524.2" sequenceAccession="NM_181524" sequenceVersion="2" change="c.835_840del">
            <Expression>NM_181524.2:c.835_840del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_852665.1" sequenceAccession="NP_852665" sequenceVersion="1" change="p.Gln279_Tyr280del">
            <Expression>NP_852665.1:p.Gln279_Tyr280del</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001822" Type="inframe_deletion" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_453" sequenceAccession="LRG_453">
            <Expression>LRG_453:g.84559_84564del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_453t1" sequenceAccession="LRG_453t1">
            <Expression>LRG_453t1:c.1735_1740del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_453p1" sequenceAccession="LRG_453p1" change="p.Gln579_Tyr580del">
            <Expression>LRG_453p1:p.Gln579_Tyr580del</Expression>
          </ProteinExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_181523.3" sequenceAccession="NM_181523" sequenceVersion="3" change="c.1735_1740delCAATAC" MANESelect="true">
            <Expression>NM_181523.3:c.1735_1740delCAATAC</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="751582616" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_181523.3(PIK3R1):c.1735_1740del (p.Gln579_Tyr580del) AND Vascular Malformations and Overgrowth" Accession="RCV001290354" Version="5">
        <ClassifiedConditionList TraitSetID="65273">
          <ClassifiedCondition>Vascular Malformations and Overgrowth</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2020-11-08" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_181523.3(PIK3R1):c.1735_1740del (p.Gln579_Tyr580del) AND CLOVES syndrome" Accession="RCV002221158" Version="1">
        <ClassifiedConditionList TraitSetID="8709">
          <ClassifiedCondition DB="MedGen" ID="C2752042">CLOVES syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2022-01-16" SubmissionCount="1">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2022-01-16" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2021-02-07" MostRecentSubmission="2022-04-12">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic/Likely pathogenic</Description>
        <DescriptionHistory Dated="2022-04-08">
          <Description>Pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="65273" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="55774" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Vascular Malformations and Overgrowth</ElementValue>
              </Name>
            </Trait>
          </TraitSet>
          <TraitSet ID="8709" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="6715" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">CLOVES syndrome</ElementValue>
                <XRef ID="MONDO:0013038" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">CLOVE SYNDROME</ElementValue>
                <XRef Type="MIM" ID="612918" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">CONGENITAL LIPOMATOUS OVERGROWTH, VASCULAR MALFORMATIONS, EPIDERMAL NEVI, AND SKELETAL/SPINAL ABNORMALITIES</ElementValue>
                <XRef Type="MIM" ID="612918" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">CLOVES</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Congenital lipomatous overgrowth, vascular malformations, and epidermal nevi</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">CONGENITAL LIPOMATOUS OVERGROWTH, VASCULAR MALFORMATIONS, AND EPIDERMAL NEVI, SOMATIC</ElementValue>
                <XRef Type="Allelic variant" ID="171834.0001" DB="OMIM" />
                <XRef Type="Allelic variant" ID="171834.0002" DB="OMIM" />
                <XRef Type="Allelic variant" ID="171834.0009" DB="OMIM" />
                <XRef Type="Allelic variant" ID="171834.0010" DB="OMIM" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">PIK3CA-related overgrowth spectrum (PROS) encompasses a range of clinical findings in which the core features are congenital or early-childhood onset of segmental/focal overgrowth with or without cellular dysplasia. Prior to the identification of PIK3CA as the causative gene, PROS was separated into distinct clinical syndromes based on the tissues and/or organs involved (e.g., MCAP [megalencephaly-capillary malformation] syndrome and CLOVES [congenital lipomatous asymmetric overgrowth of the trunk, lymphatic, capillary, venous, and combined-type vascular malformations, epidermal nevi, skeletal and spinal anomalies] syndrome). The predominant areas of overgrowth include the brain, limbs (including fingers and toes), trunk (including abdomen and chest), and face, all usually in an asymmetric distribution. Generalized brain overgrowth may be accompanied by secondary overgrowth of specific brain structures resulting in ventriculomegaly, a markedly thick corpus callosum, and cerebellar tonsillar ectopia with crowding of the posterior fossa. Vascular malformations may include capillary, venous, and less frequently, arterial or mixed (capillary-lymphatic-venous or arteriovenous) malformations. Lymphatic malformations may be in various locations (internal and/or external) and can cause various clinical issues, including swelling, pain, and occasionally localized bleeding secondary to trauma. Lipomatous overgrowth may occur ipsilateral or contralateral to a vascular malformation, if present. The degree of intellectual disability appears to be mostly related to the presence and severity of seizures, cortical dysplasia (e.g., polymicrogyria), and hydrocephalus. Many children have feeding difficulties that are often multifactorial in nature. Endocrine issues affect a small number of individuals and most commonly include hypoglycemia (largely hypoinsulinemic hypoketotic hypoglycemia), hypothyroidism, and growth hormone deficiency.</Attribute>
                <XRef ID="NBK153722" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="disease mechanism" integerValue="274">gain of function</Attribute>
                <XRef ID="GTR000571365" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000528964" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000558435" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000552540" DB="Genetic Testing Registry (GTR)" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">23946963</ID>
                <ID Source="BookShelf">NBK153722</ID>
              </Citation>
              <XRef ID="140944" DB="Orphanet" />
              <XRef ID="C2752042" DB="MedGen" />
              <XRef ID="MONDO:0013038" DB="MONDO" />
              <XRef Type="MIM" ID="612918" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="2914576" SubmissionDate="2021-02-03" DateLastUpdated="2021-02-07" DateCreated="2021-02-07">
        <ClinVarSubmissionID localKey="NCH:2755|Vascular Malformations and Overgrowth" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001478400" DateUpdated="2021-02-07" DateCreated="2021-02-07" Type="SCV" Version="1" SubmitterName="Institute for Genomic Medicine (IGM) Clinical Laboratory, Nationwide Children's Hospital" OrgID="196472" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2020-11-08">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>This alteration is of apparent somatic mosaic etiology with strong supporting evidence including no discernible strand bias, in a region absent of repetition and sequence homology, with clean, high-quality reads, having a variant allele fraction &gt;= 3% [PS2], is supported by well-established models demonstrating downstream impact of the variant on RNA structure, gene expression, or protein function [PS3], is either well-represented in cancer as identified in the COSMIC database with &gt;=20 documented instances or considered to occur in a statistically significant hotspot or region according to cancerhotspots.org database [PM_CANCER], and is in a non-repetitive region and results in a protein length change predicted to result in an in-frame protein product [PM4].</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>somatic</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>research</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PIK3R1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_181523.3:c.1735_1740delCAATAC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Vascular Malformations and Overgrowth</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB9026862</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="4887917" SubmissionDate="2022-03-29" DateLastUpdated="2022-04-12" DateCreated="2022-04-12">
        <ClinVarSubmissionID localKey="3" localKeyIsSubmitted="1" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002498580" DateUpdated="2022-04-12" DateCreated="2022-04-12" Type="SCV" Version="1" SubmitterName="Vascular Anomalies Center, Boston Children's Hospital, Harvard Medical School" OrgID="508227" OrganizationCategory="clinic" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-01-16">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>somatic</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
              <Gender>female</Gender>
              <FamilyData NumFamiliesWithSegregationObserved="1">
                <FamilyHistory>yes</FamilyHistory>
              </FamilyData>
            </Sample>
            <Method>
              <TypePlatform>Next generation sequencing</TypePlatform>
              <MethodType>clinical testing</MethodType>
              <MethodAttribute>
                <Attribute Type="TestName">Oncopnael</Attribute>
              </MethodAttribute>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
            <TraitSet DateLastEvaluated="2022-02-17" Type="Finding">
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0025104" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0002475" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0025660" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0001528" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <Name>
                  <ElementValue Type="Preferred">lymphatic malformation</ElementValue>
                </Name>
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <Name>
                  <ElementValue Type="Preferred">ectatic veins</ElementValue>
                </Name>
              </Trait>
            </TraitSet>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_181523.3:c.1735_1740del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="612918" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11207677</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="4887917" TraitType="Finding" MappingType="XRef" MappingValue="HP:0001528" MappingRef="HP">
        <MedGen CUI="C0332890" Name="Hemihypertrophy" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4887917" TraitType="Finding" MappingType="XRef" MappingValue="HP:0025660" MappingRef="HP">
        <MedGen CUI="C0555206" Name="Chiari malformation type II" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4887917" TraitType="Finding" MappingType="Name" MappingValue="lymphatic malformation" MappingRef="Preferred">
        <MedGen CUI="C0398368" Name="Lymphatic malformation" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4887917" TraitType="Finding" MappingType="Name" MappingValue="ectatic veins" MappingRef="Preferred">
        <MedGen CUI="None" Name="ectatic veins" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4887917" TraitType="Finding" MappingType="XRef" MappingValue="HP:0002475" MappingRef="HP">
        <MedGen CUI="C0025312" Name="Myelomeningocele" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4887917" TraitType="Finding" MappingType="XRef" MappingValue="HP:0025104" MappingRef="HP">
        <MedGen CUI="C0340803" Name="Capillary malformation" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4887917" TraitType="Disease" MappingType="XRef" MappingValue="612918" MappingRef="OMIM">
        <MedGen CUI="C2752042" Name="CLOVES syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2914576" TraitType="Disease" MappingType="Name" MappingValue="Vascular Malformations and Overgrowth" MappingRef="Preferred">
        <MedGen CUI="None" Name="Vascular Malformations and Overgrowth" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

